Application

15573141 · TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS

Filed 2017-11-10 · Granted · Patent 10683290 (2020-06-16) The official file ↗The patent and its PDF ↗ · Art unit 1624 · Examiner Susanna Moore Typical · CPC C07D 471/04 · BRISTOL-MYERS SQUIBB COMPANY · HENRY HADAD

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

9.1 mo

to disposition 31.2 mo

Statutes raised

103 112

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.